Medicare Enrolled
Dr. Patrick Anastasio, D.O.
Infectious Disease · Fort Walton Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Anastasio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anastasio? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Anastasio
Dr. Patrick Anastasio is an infectious disease in Fort Walton Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Anastasio performed 1,183,273 Medicare services across 2,530 unique beneficiaries.
Between the years covered by Open Payments, Dr. Anastasio received a total of $13,468 from 52 pharmaceutical and/or device companies across 720 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Anastasio is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in FL$ $13,468 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,183,273
Medicare services
Top 1% in FL for infectious disease
2,530
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~59,164 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 1,051,063 | $0 | $0 |
| Capsaicin pain patch (Qutenza) | 73,284 | $3 | $7 |
| Injection, omadacycline, 1 mg | 17,910 | $3 | $8 |
| Injection, oritavancin (kimyrsa), 10 mg | 9,000 | $33 | $116 |
| Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter | 8,575 | $1,037 | $1,390 |
| Injection, meropenem, 100 mg | 4,887 | $0 | $2 |
| Omalizumab injection (Xolair) for asthma/allergy | 4,410 | $30 | $107 |
| Injection, ertapenem sodium, 500 mg | 2,167 | $11 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 2,156 | $48 | $178 |
| Ceftriaxone antibiotic injection | 2,006 | $0 | $12 |
| Injection, cefepime hydrochloride, 500 mg | 1,773 | $1 | $4 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 986 | $22 | $83 |
| Office visit, established patient (30-39 min) | 926 | $95 | $336 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 540 | $15 | $57 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 394 | $119 | $396 |
| Zenith amniotic membrane, per square centimeter | 320 | $765 | $1,000 |
| Hospital follow-up visit, moderate complexity | 283 | $57 | $203 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 226 | $122 | $419 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 214 | $18 | $42 |
| Removal of skin and tissue, 20.0 sq cm or less | 200 | $96 | $349 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 182 | $3 | $9 |
| Drug injection, under skin or into muscle | 181 | $11 | $37 |
| Injection of additional new drug or substance into vein | 138 | $12 | $50 |
| Removal of tissue from wound, 20.0 sq cm or less | 134 | $77 | $215 |
| Application of skin substitute graft to wound of trunk, arms, or legs, each additional 25.0 sq cm of wound 100.0 sq cm or less | 120 | $19 | $68 |
| COVID-19 vaccine administration | 106 | $40 | $120 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 105 | $16 | $58 |
| New patient office visit (45-59 min) | 95 | $126 | $450 |
| COVID-19 vaccine (Pfizer bivalent) | 92 | $128 | $393 |
| Injection, diphenhydramine hcl, up to 50 mg | 88 | $1 | $3 |
| Flu vaccine administration | 73 | $30 | $36 |
| Flu vaccine, quadrivalent | 70 | $76 | $144 |
| Other procedure on nervous system | 64 | $153 | $974 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 62 | $1 | $7 |
| Infusion into a vein for hydration, each additional hour | 59 | $10 | $38 |
| Initial hospital admission, high complexity | 53 | $127 | $475 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 51 | $48 | $270 |
| Adm sarscv2 bvl 30mcg/.3ml a | 45 | $40 | $65 |
| Adm sarscv2 bvl 50mcg/.5ml a | 45 | $40 | $65 |
| Hospital follow-up visit, high complexity | 43 | $84 | $258 |
| Strapping, unna boot | 42 | $48 | $250 |
| Insertion of tube for infusion with imaging guidance and review by radiologist, patient 5 years or older | 27 | $294 | $811 |
| Office visit, established patient, complex (40-54 min) | 20 | $128 | $477 |
| New patient office visit, complex (60-74 min) | 19 | $154 | $562 |
| Punch biopsy, first skin growth | 14 | $97 | $328 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 13 | $40 | $156 |
| Punch biopsy, each additional skin growth | 12 | $46 | $159 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
92.4% medium
7.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,468
Total received (2018-2024)
Avg $1,924/year across 7 years
Top 12% in FL for infectious disease
52
Companies
720
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,392 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$76 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$172
2023$1,955
2022$2,246
2021$2,886
2020$1,658
2019$2,520
2018$2,031
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Paratek Pharmaceuticals, Inc.
$1,322
Insmed, Inc.
$1,221
Horizon Therapeutics plc
$968
Gilead Sciences, Inc.
$899
CIPLA USA INC.
$857
AbbVie Inc.
$782
Allergan Inc.
$741
Melinta Therapeutics, LLC
$711
ViiV Healthcare Company
$689
Melinta Therapeutics, Inc.
$499
Merck Sharp & Dohme Corporation
$446
AbbVie, Inc.
$375
ABBVIE INC.
$374
Allergan, Inc.
$297
Ferring Pharmaceuticals Inc.
$287
TELA Bio, Inc.
$228
GRT US Holding, Inc.
$226
Organogenesis Inc.
$207
Octapharma USA, Inc.
$204
Janssen Biotech, Inc.
$199
La Jolla Pharmaceutical Company
$190
Merck Sharp & Dohme LLC
$177
KCI USA, Inc
$151
AstraZeneca Pharmaceuticals LP
$144
Astellas Pharma US Inc
$133
Smith & Nephew, Inc.
$116
Smith+Nephew, Inc.
$115
Theratechnologies Inc.
$80
PFIZER INC.
$76
Genentech USA, Inc.
$70
GlaxoSmithKline, LLC.
$67
AIMMUNE THERAPEUTICS, INC.
$64
Lundbeck LLC
$60
ConvaTec Inc.
$53
Urgo Medical North America, LLC
$44
Takeda Pharmaceuticals U.S.A., Inc.
$41
Amgen Inc.
$38
Averitas Pharma Inc.
$35
Osiris Therapeutics Inc.
$33
KCI USA, Inc.
$31
Sun Pharmaceutical Industries Inc.
$25
Vyera Pharmaceuticals, LLC
$24
Teva Pharmaceuticals USA, Inc.
$21
AngioDynamics, Inc.
$21
Relypsa, Inc.
$20
Alexion Pharmaceuticals, Inc.
$20
Shire North American Group Inc
$18
TETRAPHASE PHARMACEUTICALS, INC.
$17
Seqirus USA Inc
$16
Napo Pharmaceuticals Inc
$14
Grifols USA, LLC
$12
ACELL, INC.
$11
Top 3 companies account for 26.1% of total payments
Associated products mentioned in payments ›
ACTIMMUNE · ACTIV.A.C. · ACTIVAC · AMBISOME · APRETUDE · AVYCAZ · Apligraf · Arikayce · Baxdela · Biktarvy · CABENUVA · CRESEMBA · DALVANCE · DIFICID · DOVATO · Daraprim Tablet 25mg · EGRIFTA · ENTYVIO · EVUSHELD · Epclusa · FLUCELVAX QUADRIVALENT · GATTEX · Grafix PL PRIME · ILUMYA · INFLECTRA · INNOVAMATRIX AC · ISENTRESS · JULUCA · KRYSTEXXA · KerraCel Ag · Kimyrsa · MAVYRET · Mavyret · Mytesi · NUZYRA · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Orbactiv · OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) · PANZYGA · PICO · PIFELTRO · PREZCOBIX · Prolastin-C Liquid · Puraply · QUTENZA · Qutenza · REBYOTA · SHINGRIX · SYMTUZA · Santyl · Soliris · Stravix · Symtuza · TEFLARO · TEZSPIRE · TRIUMEQ · TROGARZO · Truxima · VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP · VOWST · VYEPTI · Vabomere · Veltassa · XERAVA · Xerava · Xofluza · Xolair · ZEMDRI (PLAZOMICIN) · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1 per 100 Medicare services performed
Geographic Context
Infectious Diseases within 10 mi
6
Per 100K population
2.8
County median income
$79,097
Nearest hospital
HCA FLORIDA FORT WALTON-DESTIN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Anastasio is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 12%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Anastasio experienced with daptomycin antibiotic injection?
Based on Medicare claims data, Dr. Anastasio performed 1,051,063 daptomycin antibiotic injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anastasio receive payments from pharmaceutical companies?
Yes. Dr. Anastasio received a total of $13,468 from 52 companies across 720 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anastasio's costs compare to other infectious diseases in Fort Walton Beach?
Dr. Anastasio's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anastasio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Fort Walton Beach
Browse infectious diseases in Fort Walton Beach ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in FL
Infectious Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in FL
Which FL infectious diseases receive the most from drug and device companies.
By company
Paratek Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Paratek Pharmaceuticals, Inc..
By company
Insmed, Inc. Payments to Doctors
See all physicians who received payments from Insmed, Inc..
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology